C. Visseren Grul : rechercher sur Z-Library

Le plus grand référentiel d'articles scientifiques au monde. 70,000,000+ d'articles gratuitement.

Don't use scam websites

Livres
Articles (50)
Les plus populaires
Liste
- Liste
- Tableau

1

Survival without toxicity for cisplatin plus pemetrexed versus cisplatin plus gemcitabine in chemonaïve patients with advanced non-small cell lung cancer: A risk-benefit analysis of a large phase III study

Giorgio V. Scagliotti, Keunchil Park, Shekar Patil, Janusz Rolski, Tuncay Goksel, Renato Martins, Steven J.M. Gans, Carla Visseren-Grul, Patrick Peterson

Journal:

European Journal of Cancer

Année:

2009

Langue:

english

Fichier:

PDF, 236 KB

english, 2009

2

1447 POSTER First-line Treatment of Non-Small Cell Lung Cancer Under Routine Conditions: Observational Study (FRAME)

D. Moro-Sibilot, E. Smit, J. de Castro, K. Lesniewski-Kmak, J. Aerts, K. Kraaij, C. Visseren Grul, Y. Dyachkova, K. Taipale, P. Schnabel

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 45 KB

english, 2011

3

Influence of histology and biomarkers on first-line treatment of advanced non-small cell lung cancer in routine care setting: Baseline results of an observational study (FRAME)

Schnabel, Philipp A., Smit, Egbert, Carpeo, Javier de Castro, Leniewski-Kmak, Krzysztof, Aerts, Joachim, Kraaij, Kees, Visseren-Grul, Carla, Dyachkova, Yulia, Taipale, Kaisa, Girvan, Allicia, Moro-Sib

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 217 KB

english, 2012

4

Pemetrexed Therapy in Elderly Patients With Good Performance Status: Analysis of Two Phase III Trials of Patients With Nonsquamous Non–Small-Cell Lung Cancer

Cesare Gridelli, Thomas Brodowicz, Corey J. Langer, Patrick Peterson, Mominul Islam, Susan C. Guba, Patti Moore, Carla M. Visseren-Grul, Giorgio Scagliotti

Journal:

Clinical Lung Cancer

Année:

2012

Langue:

english

Fichier:

PDF, 320 KB

english, 2012

5

Malignant peritoneal mesothelioma—Results from the International Expanded Access Program using pemetrexed alone or in combination with a platinum agent

Carteni, G., Manegold, C., Garcia, G. Martin, Siena, S., Zielinski, C.C., Amadori, D., Liu, Y., Blatter, J., Visseren-Grul, C., Stahel, R.

Journal:

Année:

2009

Langue:

english

Fichier:

PDF, 476 KB

english, 2009

6

Treatment rationale and study design for a phase III, double-blind, placebo-controlled study of maintenance pemetrexed plus best supportive care versus best supportive care immediately following induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small cell lung cancer

Luis G Paz-Ares, Sedat Altug, Alexandra Thareau Vaury, Jesús Corral Jaime, Francesca Russo, Carla Visseren-Grul

Journal:

Année:

2010

Langue:

english

Fichier:

PDF, 491 KB

english, 2010

7

Pemetrexed Use in the Adjuvant Setting for Completely Resectable Non–Small-Cell Lung Cancer

Simon, George R., Manegold, Christian, Barker, Scott S., Treat, Joseph A., Visseren-Grul, Carla, Obasaju, Coleman

Journal:

Clinical Lung Cancer

Année:

2013

Langue:

english

Fichier:

PDF, 239 KB

english, 2013

8

Home administration of maintenance pemetrexed for patients with advanced non-squamous non-small cell lung cancer: rationale, practicalities and phase II feasibility study design

Lal, Rohit, Bourayou, Nawel, Hillerdal, Gunnar, Nicolson, Marianne, Vikstrom, Anders, Lorenzo, Maria, D’yachkova, Yulia, Barriga, Susana, Visseren-Grul, Carla

Journal:

Health and Quality of Life Outcomes

Année:

2013

Langue:

english

Fichier:

PDF, 269 KB

english, 2013

9

9072 POSTER Pemetrexed (Pern) Maintenance Therapy in Elderly Patients (Pts) With Good Performance Status (PS) – Analysis of PARAMOUNT Phase III Study of Pern Versus Placebo in Advanced Nonsquamous Non-small Cell Lung Cancer (NSCLC)

Gridelli, C., Thomas, M., Prabhash, K., Kouri, C. El, Blackhall, F., Melemed, S., Zimmermann, A., Chouaki, N., Visseren-Grul, C., Paz-Ares, L.G.

Journal:

European Journal of Cancer

Année:

2011

Langue:

english

Fichier:

PDF, 43 KB

english, 2011

10

9077 Phase 2 study of pemetrexed and cisplatin plus either enzastaurin or placebo in chemonaive patients with advanced NSCLC

Reck, M., Ramlau, R., VonPawel, J., Antonio, B. San, Visseren-Grul, C., Chouaki, N., Eschbach, C., Szczesna, A., Vansteenkiste, J.

Journal:

European Journal of Cancer Supplements

Année:

2009

Langue:

english

Fichier:

PDF, 51 KB

english, 2009

11

FRAME : traitement de première ligne (L1) des cancers bronchiques non à petites cellules (CBNPC) en routine clinique, résultats des analyses de la cohorte française

Ducolone, A., Dixmier, A., Monnet, I., Foucher, P., Botrus, P., Moreau, L., Sire, C., Prevost, A., Couraud, S., Falchero, L., Janicot, H., Evans, D., Visseren Grul, C., Dvachkova, Y., Nacerddine, K.,

Journal:

Revue des Maladies Respiratoires

Année:

2013

Langue:

french

Fichier:

PDF, 87 KB

french, 2013

12

6519 ORAL Favorable benefit to risk profile for pemetrexed plus cisplatin versus gemcitabine plus cisplatin in a large phase III study of first-line therapy in advanced non-small cell lung cancer

Scagliotti, G., Park, K., Patil, S., Rolski, J., Gorksel, T., Gans, S.J.M., Martins, R., Visseren-Grul, C., Peterson, P.

Journal:

European Journal of Cancer Supplements

Année:

2007

Langue:

english

Fichier:

PDF, 57 KB

english, 2007

13

6571 POSTER Open-label study of pemetrexed (P) alone or in combination with a platinum in patients (pts) with peritoneal mesothelioma (PM): results from the international expanded access program (EAP)

Carteni, G., Manegold, C., Martin Garcia, G., Siena, S., Zielinski, C.C., Amadori, D., Liu, Y., Visseren-Grul, C., Blatter, J., Stahel, R.

Journal:

European Journal of Cancer Supplements

Année:

2007

Langue:

english

Fichier:

PDF, 76 KB

english, 2007

14

Efficacy and safety of maintenance pemetrexed in patients with advanced nonsquamous non-small cell lung cancer following pemetrexed plus cisplatin induction treatment: A cross-trial comparison of two phase III trials

Scagliotti, G.V., Gridelli, C., de Marinis, F., Thomas, M., Dediu, M., Pujol, J.-L., Manegold, C., San Antonio, B., Peterson, P.M., John, W., Chouaki, N., Visseren-Grul, C., Paz-Ares, L.G.

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 739 KB

english, 2014

15

Second-line therapy for non-small cell lung cancer in clinical practice: final results and treatment pathways from the SELECTTION observational study

Vergnenegre, Alain, Smit, Egbert F., Toy, Elisabeth, Parente, Barbara, Schmitz, Stephan, Kraaij, Kees, Soldatenkova, Victoria, Visseren-Grul, Carla, Zanotti, Giovanni, Taipale, Kaisa, Moro-Sibilot, De

Journal:

Current Medical Research and Opinion

Année:

2012

Langue:

english

Fichier:

PDF, 407 KB

english, 2012

16

Bevacizumab combined with pemetrexed plus cisplatin followed by maintenance bevacizumab/pemetrexed as first-line treatment of advanced non-squamous non-small cell lung cancer: A single-arm Phase 2 study

Santoro, Armando, Hillerdal, Gunnar N., Hoeffken, Gert, Favaretto, Adolfo, Carrion, Ramon Perez, Visseren-Grul, Carla, Ameryckx, Sophie, Helsberg, Karin, Soldatenkova, Victoria, Bourayou, Nawel, Søren

Journal:

Année:

2014

Langue:

english

Fichier:

PDF, 596 KB

english, 2014

17

Reply to S. Barni et al, K.R. Dearing et al, and N. Murray

Paz-Ares, L. G., de Marinis, F., Visseren-Grul, C., Gridelli, C.

Journal:

Journal of Clinical Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 295 KB

english, 2014

18

Second-line therapy for NSCLC in clinical practice: baseline results of the European SELECTTION observational study

Moro-Sibilot, Denis, Vergnenegre, Alain, Smit, Egbert F., Toy, Elisabeth, Parente, Barbara, Schmitz, Stephan, Kraaij, Kees, Visseren-Grul, Carla, Soldatenkova, Victoria, Arellano, Jorge, Leteneux, Cla

Journal:

Current Medical Research and Opinion

Année:

2010

Langue:

english

Fichier:

PDF, 417 KB

english, 2010

19

NSCLC Patients With Brain Metastases Treated With Platinum-Based Doublets as First-Line Therapy: Analyses From the European FRAME Observational Study

Smit, E., Moro-Sibilot, D., de Castro Carpeño, J., Lesniewski-Kmak, K., Aerts, J., Villatoro, R., Kraaij, K., Nacerddine, K., D'yachkova, Y., Smith, K., Girvan, A., Visseren-Grul, C., Schnabel, P.

Journal:

International Journal of Radiation Oncology*Biology*Physics

Année:

2014

Langue:

english

Fichier:

PDF, 59 KB

english, 2014

20

A Phase II Randomized Study of Cisplatin-Pemetrexed plus either Enzastaurin or Placebo in Chemonaive Patients with Advanced Non-Small Cell Lung Cancer

Vansteenkiste, Johan, Ramlau, Rodryg, von Pawel, Joachim, San Antonio, Belen, Eschbach, Corinna, Szczesna, Aleksandra, Kennedy, Liam, Visseren-Grul, Carla, Chouaki, Nadia, Reck, Martin

Journal:

Année:

2012

Langue:

english

Fichier:

PDF, 102 KB

english, 2012

21

Phase III Study of Pemetrexed Plus Carboplatin Compared With Etoposide Plus Carboplatin in Chemotherapy-Naive Patients With Extensive-Stage Small-Cell Lung Cancer

Socinski, M. A., Smit, E. F., Lorigan, P., Konduri, K., Reck, M., Szczesna, A., Blakely, J., Serwatowski, P., Karaseva, N. A., Ciuleanu, T., Jassem, J., Dediu, M., Hong, S., Visseren-Grul, C., Hanausk

Journal:

Journal of Clinical Oncology

Année:

2009

Langue:

english

Fichier:

PDF, 128 KB

english, 2009

22

Oral Administration of Gemcitabine in Patients with Refractory Tumors: A Clinical and Pharmacologic Study

Veltkamp, S. A., Jansen, R. S., Callies, S., Pluim, D., Visseren-Grul, C. M., Rosing, H., Kloeker-Rhoades, S., Andre, V. A.M., Beijnen, J. H., Slapak, C. A., Schellens, J. H.M.

Journal:

Clinical Cancer Research

Année:

2008

Langue:

english

Fichier:

PDF, 534 KB

english, 2008

23

Phase I Pharmacokinetic and Pharmacodynamic Study of the Oral Protein Kinase C -Inhibitor Enzastaurin in Combination with Gemcitabine and Cisplatin in Patients with Advanced Cancer

Rademaker-Lakhai, J. M., Beerepoot, L. V., Mehra, N., Radema, S. A., van Maanen, R., Vermaat, J. S., Witteveen, E. O., Visseren-Grul, C. M., Musib, L., Enas, N., van Hal, G., Beijnen, J. H., Schellens

Journal:

Clinical Cancer Research

Année:

2007

Langue:

english

Fichier:

PDF, 422 KB

english, 2007

24

PARAMOUNT

Reck, Martin, Paz-Ares, Luis G., de Marinis, Filippo, Molinier, Olivier, Sahoo, Tarini Prasad, Laack, Eckart, John, William, Zimmermann, Annamaria H., Visseren-Grul, Carla, Gridelli, Cesare

Journal:

Journal of Thoracic Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 1.26 MB

english, 2014

25

Randomized Phase III Study of Surgery Alone or Surgery Plus Preoperative Cisplatin and Gemcitabine in Stages IB to IIIA Non-Small-Cell Lung Cancer

Scagliotti, G. V., Pastorino, U., Vansteenkiste, J. F., Spaggiari, L., Facciolo, F., Orlowski, T. M., Maiorino, L., Hetzel, M., Leschinger, M., Visseren-Grul, C., Torri, V.

Journal:

Journal of Clinical Oncology

Année:

2012

Langue:

english

Fichier:

PDF, 172 KB

english, 2012

26

Prognostic and predictive factors in a randomized phase III trial comparing cisplatin-pemetrexed versus cisplatin-gemcitabine in advanced non-small-cell lung cancer

Syrigos, K. N., Vansteenkiste, J., Parikh, P., von Pawel, J., Manegold, C., Martins, R. G., Simms, L., Sugarman, K. P., Visseren-Grul, C., Scagliotti, G. V.

Journal:

Annals of Oncology

Année:

2010

Langue:

english

Fichier:

PDF, 94 KB

english, 2010

27

Feasibility of home delivery of pemetrexed in patients with advanced non-squamous non-small cell lung cancer

Lal, R., Hillerdal, G.N., Shah, R.N.H., Crosse, B., Thompson, J., Nicolson, M., Vikström, A., Potter, V.A., Visseren-Grul, C., Lorenzo, M., D’yachkova, Y., Bourayou, N., Summers, Y.J.

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 676 KB

english, 2015

28

Final results from a Phase II study of pemetrexed and cisplatin with concurrent thoracic radiation after Pem-Cis induction in patients with unresectable locally advanced non-squamous non-small cell lung cancer (NSCLC)

Garrido, Pilar, Engel-Riedel, Walburga, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Ameryckx, Sophie, Soldatenkova, Victoria, Chouaki, Nadia, Novello, Sil

Journal:

Année:

2015

Langue:

english

Fichier:

PDF, 712 KB

english, 2015

29

Cisplatin in the modern era: the backbone of first-line chemotherapy for non-small cell lung cancer

Fennell, D.A., Summers, Y., Cadranel, J., Benepal, T., Christoph, D.C., Lal, R., Das, M., Maxwell, F., Visseren-Grul, C., Ferry, D.

Journal:

Cancer Treatment Reviews

Année:

2016

Langue:

english

Fichier:

PDF, 692 KB

english, 2016

30

10.1023/a:1008364327684

von Minckwitz, G., Bauknecht, T., Visseren-Grul, C. M., Neijt, J. P.

Journal:

Annals of Oncology

Année:

1999

Langue:

english

Fichier:

PDF, 237 KB

english, 1999

31

Randomized Double-Blind Phase II Trial Comparing Gemcitabine Plus LY293111 Versus Gemcitabine Plus Placebo in Advanced Adenocarcinoma of the Pancreas

Saif, Muhammad Wasif, Oettle, H, Vervenne, W L., Thomas, J P., Spitzer, G, Visseren-Grul, C, Enas, N, Richards, D A.

Journal:

The Cancer Journal

Année:

2009

Langue:

english

Fichier:

PDF, 227 KB

english, 2009

32

Safety and Resource Utilization by Non-small Cell Lung Cancer Histology: Results from the Randomized Phase III Study of Pemetrexed Plus Cisplatin versus Gemcitabine Plus Cisplatin in Chemonaïve Patients with Advanced Non-small Cell Lung Cancer

Novello, Silvia, Pimentel, Francisco Luis, Douillard, Jean-Yves, O'Brien, Mary, von Pawel, Joachim, Eckardt, John, Liepa, Astra M., Simms, Lorinda, Visseren-Grul, Carla, Paz-Ares, Luis

Journal:

Journal of Thoracic Oncology

Année:

2010

Langue:

english

Fichier:

PDF, 444 KB

english, 2010

33

C5-01: Open-label study of pemetrexed alone or in combination with a platinum in chemonaïve patients (pts) with malignant pleural mesothelioma (MPM): Results from the International Expanded Access Program (EAP)

Manegold, Christian, Santoro, Armando, O'Brien, Mary E.r., Stahel, Rolf A., Nackaerts, Kristiaan, Bass, Paul, Paz-Ares, Luis, Sundstrom, Stein, Visseren-Grul, Carla, Blatter, Johannes

Journal:

Journal of Thoracic Oncology

Année:

2007

Langue:

english

Fichier:

PDF, 179 KB

english, 2007

34

Safety Analyses of Pemetrexed-cisplatin and Pemetrexed Maintenance Therapies in Patients With Advanced Non-squamous NSCLC: Retrospective Analyses From 2 Phase III Studies

Langer, Corey J., Paz-Ares, Luis G., Wozniak, Antoinette J., Gridelli, Cesare, de Marinis, Filippo, Pujol, Jean-Louis, San Antonio, Belen, Chen, Jian, Liu, Jingyi, Oton, Ana B., Visseren-Grul, Carla,

Journal:

Clinical Lung Cancer

Année:

2017

Langue:

english

Fichier:

PDF, 1.12 MB

english, 2017

35

Pemetrexed-cisplatin with concurrent thoracic radiation after pemetrexed-cisplatin induction in patients with unresectable locally advanced non-squamous NSCLC: results by age subgroup

Garrido, Pilar, Chouaki, Nadia, Serke, Monika, Giraud, Philippe, Ricardi, Umberto, Vallejo, Carmen, Visseren-Grul, Carla, Soldatenkova, Victoria, Novello, Silvia

Journal:

Année:

2017

Langue:

english

Fichier:

PDF, 821 KB

english, 2017

36

Evaluation of changes in renal function in PARAMOUNT: a phase III study of maintenance pemetrexed plus best supportive care versus placebo plus best supportive care after induction treatment with pemetrexed plus cisplatin for advanced nonsquamous non-small-cell lung cancer

Middleton, Gary, Gridelli, Cesare, De Marinis, Filippo, Pujol, Jean-Louis, Reck, Martin, Ramlau, Rodryg, Parente, Barbara, Pieters, Thierry, Visseren-Grul, Carla M., San Antonio, Bélen, John, William

Journal:

Current Medical Research and Opinion

Année:

2018

Langue:

english

Fichier:

PDF, 727 KB

english, 2018

37

1202PPEMETREXED (PEM) AND CISPLATIN (CIS) WITH CONCURRENT THORACIC RADIATION AFTER PEM + CIS INDUCTION IN PATIENTS (PTS) WITH UNRESECTABLE LOCALLY ADVANCED (LA) NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS-NSCLC): RESULTS IN DIFFERENT AGE GROUPS (≤70 YRS, >70 YRS)

Lopez, P. Garrido, Novello, S., Engel-Riedel, W., Serke, M., Giraud, P., Visseren-Grul, C.M., Ameryckx, S., Soldatenkova, V., Chouaki, N.

Journal:

Annals of Oncology

Année:

2014

Langue:

english

Fichier:

PDF, 69 KB

english, 2014

38

P3.01-75 RELAY+, an Exploratory Study of Gefitinib with Ramucirumab in Untreated Patients with EGFR Mutation-Positive Metastatic NSCLC

Nishio, M., Nishio, K., Suzukawa, K., Omori, Y., Enatsu, S., Visseren-Grul, C., Nakagawa, K.

Journal:

Journal of Thoracic Oncology

Année:

2018

Langue:

english

Fichier:

PDF, 138 KB

english, 2018

39

P3.01-75 RELAY+, an Exploratory Study of Gefitinib with Ramucirumab in Untreated Patients with EGFR Mutation-Positive Metastatic NSCLC

Nishio, M., Nishio, K., Suzukawa, K., Omori, Y., Enatsu, S., Visseren-Grul, C., Nakagawa, K.

Journal:

Journal of Thoracic Oncology

Année:

2018

Fichier:

PDF, 138 KB

2018

40

P1.13-30 Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor and its Relationship to NSCLC Patient Outcomes in the REVEL Trial

Garon, E., Tsao, A., Reck, M., Levy, B., Visseren-Grul, C., Mao, H., Sashegyi, A., Chaudhry, A.

Journal:

Journal of Thoracic Oncology

Année:

2018

Fichier:

PDF, 263 KB

2018

41

1203PAN EXPLORATORY PHASE 2 STUDY OF PEMETREXED (PEM) AND CISPLATIN (CIS) AS PREOPERATIVE CHEMOTHERAPY (CT) IN THE TREATMENT OF STAGE IIIAN2 NONSQUAMOUS NON-SMALL CELL LUNG CANCER (NS NSCLC)

Pastorino, U., Platania, M., Rea, F., Schiavon, M., Ceribelli, A., Mussi, A., Monica, V., Das, M., Soldatenkova, V., Visseren-Grul, C.M., Scagliotti, G.

Journal:

Annals of Oncology

Année:

2014

Fichier:

PDF, 62 KB

2014

42

1252PNSCLC PATIENTS WITH BRAIN METASTASES TREATED WITH PLATINUM-BASED DOUBLETS AS FIRST-LINE THERAPY: ANALYSES FROM THE EUROPEAN FRAME OBSERVATIONAL STUDY

Moro-Sibilot, D., Smit, E.F., Carpeño, J. De Castro, Lesniewski-Kmak, K., Aerts, J.G., Villatoro, R., Kraaij, K., Nacerddine, K., Dyachkova, Y., Smith, K., Girvan, A., Visseren-Grul, C.M., Schnabel, P

Journal:

Annals of Oncology

Année:

2014

Fichier:

PDF, 70 KB

2014

43

1257PEVALUATION OF CHANGES IN RENAL FUNCTION IN A PHASE III STUDY OF MAINTENANCE (MTC) PEMETREXED (PEM) PLUS BEST SUPPORTIVE CARE (BSC) VERSUS PLACEBO (PLB) PLUS BSC AFTER INDUCTION TREATMENT (TX) WITH PEM PLUS CISPLATIN FOR ADVANCED NONSQUAMOUS NON-SMALL CELL LUNG CANCER (PARAMOUNT)

Middleton, G., Gridelli, C., De Marinis, F., Pujol, J., Reck, M., Ramlau, R., Parente, M.B., Pieters, T., Visseren-Grul, C.M., Antonio, B. San, John, W., Zimmermann, A., Chouaki, N., Paz-Ares, L.

Journal:

Annals of Oncology

Année:

2014

Fichier:

PDF, 67 KB

2014

44

1239PFEASIBILITY OF HOME DELIVERY (HD) OF MAINTENANCE PEMETREXED (PEM) THERAPY FOR ADVANCED NONSQUAMOUS NON SMALL CELL LUNG CANCER (ADV NSQNSCLC)

Lal, R., Summers, Y., Shah, R., Crosse, B., Thompson, J., Nicolson, M.C., Potter, V., Visseren-Grul, C.M., Vikström, A., Lorenzo, M., D'Yachkova, Y., Bourayou, N., Hillerdal, G.

Journal:

Annals of Oncology

Année:

2014

Fichier:

PDF, 69 KB

2014

45

P1.18-01 RELAY EU/US Subset: Ramucirumab Plus Erlotinib Improves Progression-Free Survival in First-Line EGFR Mutation-Positive NSCLC

Aix, S., Novello, S., Garon, E., Nakagawa, K., Nadal, E., Moro-Sibilot, D., Garcia, M. Alonso, Fabre, E., Frimodt-Moller, B., Zimmermann, A., Visseren-Grul, C., Reck, M.

Journal:

Journal of Thoracic Oncology

Année:

2019

Fichier:

PDF, 149 KB

2019

46

Patient-reported outcomes in RELAY, a Phase 3 trial of ramucirumab plus erlotinib versus placebo plus erlotinib in untreated EGFR -mutated metastatic NSCLC

Yoh, Kiyotaka, Atagi, Shinji, Reck, Martin, Garon, Edward B, Ponce Aix, Santiago, Moro-Sibilot, Denis, Winfree, Katherine B, Frimodt-Moller, Bente, Zimmermann, Annamaria, Visseren-Grul, Carla, Nakagaw

Journal:

Current Medical Research and Opinion

Année:

2020

Fichier:

PDF, 1.08 MB

2020

47

1298P RELAY, ramucirumab plus erlotinib (RAM+ERL) versus placebo plus erlotinib (P+ERL) in untreated EGFR mutated metastatic non-small cell lung cancer (NSCLC): Exposure-response relationship

Nakagawa, K., Garon, E., Gao, L., Callies, S., Zimmermann, A., Walgren, R., Visseren-Grul, C., Reck, M.

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 130 KB

2020

48

1294P RELAY, erlotinib plus ramucirumab or placebo in untreated EGFR-mutated metastatic NSCLC: Outcomes by EGFR mutation type

Nakagawa, K., Nadal, E., Garon, E.B., Nishio, M., Seto, T., Yamamoto, N., Park, K., Shih, J-Y., Frimodt-Moller, B., Zimmermann, A.H., Visseren-Grul, C.M., Reck, M.

Journal:

Annals of Oncology

Année:

2020

Fichier:

PDF, 93 KB

2020

49

Dual EGFR/VEGF pathway inhibition: a promising strategy for patients with EGFR-mutant NSCLC

Le, Xiuning, Nilsson, Monique, Goldman, Jonathan, Reck, Martin, Nakagawa, Kazuhiko, Kato, Terafumi, Ares, Luis Paz, Frimodt-Moller, Bente, Wolff, Katharina, Visseren-Grul, Carla, Heymach, John V., Gar

Journal:

Journal of Thoracic Oncology

Année:

2020

Fichier:

PDF, 1.50 MB

2020

50

Paramount: Descriptive Subgroup Analyses of Final Overall Survival (OS) for the Phase III Study of Maintenance Pemetrexed (PEM) Versus Placebo (PLB) Following Induction Treatment with PEM Plus Cisplatin (CIS) for Advanced Nonsquamous (NS) Non-Small Cell Lung Cancer (NSCLC)

Reck, M., Paz-Ares, L., De Marinis, F., Molinier, O., Prasad Sahoo, T., Laack, E., John, W., Zimmermann, A., Visseren-Grul, C.M., Gridelli, C.

Journal:

Annals of Oncology

Année:

2012

Fichier:

PDF, 57 KB

2012